News
Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...
†Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States ‡ Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback